Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.37 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 5/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 6/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16589233 | 0.83 | CYP2C9 (0.45) | NPSR1GLO1MEN1KMT2AGAA | |
| SCHEMBL5795696 | 0.76 | ALDH1A1 (0.42) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL7975645 | 0.67 | ALDH1A1 (0.40) | NPSR1GLO1MEN1KMT2AGAA | |
| SCHEMBL7262 | 0.64 | ALDH1A1 (0.62) | NPSR1GLO1MEN1KMT2AGAA | |
| SCHEMBL9823358 | 0.64 | ALDH1A1 (0.62) | NPSR1GLO1MEN1KMT2AGAA | |
| SCHEMBL1331989 | 0.64 | ALDH1A1 (0.62) | NPSR1GLO1MEN1KMT2AGAA | |
| SCHEMBL13269051 | 0.64 | NPSR1 (0.62) | NPSR1GLO1MEN1KMT2AGAA | |
| SCHEMBL1942274 | 0.64 | NPSR1 (0.62) | NPSR1GLO1MEN1KMT2AGAA | |
| SCHEMBL315410 | 0.63 | HSD17B10 (0.49) | NPSR1MEN1KMT2AGAAMGAM | |
| SCHEMBL5792153 | 0.63 | ALDH1A1 (0.37) | MEN1KMT2AGAAMGAMSI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10301289-B2 | Method for the preparation of triazole compounds | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2019-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10301289-B2 | Method for the preparation of triazole compounds | CYP4B1, BRI3BP, BRD4 | NPSR1 2468/4885GLO1 3843/4885MEN1 819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.